TRANSLATIONAL RISK

Translational risk in CNS drug development

In development — a look at where CNS programmes most often lose ground between model and clinic.

PRECLINICAL MODELS

Human-relevant models and the future of preclinical research

In development — what organoids and other human-relevant systems change, and what they don't yet.

EVIDENCE EVALUATION

How AI changes scientific evidence evaluation

In development — where AI genuinely accelerates evidence review, and where it introduces new risk.

CNS DELIVERY

Blood–brain barrier delivery: scientific and translational challenges

In development — the recurring gap between delivery data and clinical translation in CNS programmes.

Have a topic you'd want covered, or a question these touch on? Get in touch.